止吐控制：5-羟色胺3拮抗剂：临床结果综述，尤其侧重于昂丹司琼。 - Suppr | 超能文献

Antiemetic control: 5-HT3 antagonists: review of clinical results, with particular emphasis on ondansetron.

作者信息

Kidgell A E, Butcher M E, Brown G W

机构信息

Clinical Research (Infection and Oncology) Glaxo Group Research Ltd., Greenford, Middlesex, U.K.

出版信息

Cancer Treat Rev. 1990 Sep;17(2-3):311-7. doi: 10.1016/0305-7372(90)90063-l.

DOI:10.1016/0305-7372(90)90063-l

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Antiemetic control: 5-HT3 antagonists: review of clinical results, with particular emphasis on ondansetron.止吐控制：5-羟色胺3拮抗剂：临床结果综述，尤其侧重于昂丹司琼。

Cancer Treat Rev. 1990 Sep;17(2-3):311-7. doi: 10.1016/0305-7372(90)90063-l.

2

5-HT3 receptor antagonists, a new approach in emesis: a review of ondansetron, granisetron and tropisetron.5-羟色胺3受体拮抗剂：止吐新方法——对昂丹司琼、格拉司琼和托烷司琼的综述

Anticancer Drugs. 1991 Aug;2(4):343-55. doi: 10.1097/00001813-199108000-00003.

3

Antiemetic action of 5-HT3 receptor antagonists: review of preclinical and clinical results with ICS 205-930.5-羟色胺3受体拮抗剂的止吐作用：ICS 205-930的临床前和临床结果综述

Cancer Treat Rev. 1990 Sep;17(2-3):301-5. doi: 10.1016/0305-7372(90)90061-j.

4

5HT3-receptor antagonists as antiemetics in cancer.

Drug Ther Bull. 2005 Aug;43(8):57-62. doi: 10.1136/dtb.2005.43857.

5

[Recent improvements in antiemetic therapy].[抗呕吐治疗的近期进展]

Tumori. 1997;83(2 Suppl):S3-14.

6

Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).减少恶心和呕吐方面的进展。昂丹司琼（枢复宁）、格拉司琼（康泉）和托烷司琼（呕必停）的比较。

Cancer. 1995 Aug 1;76(3):343-57. doi: 10.1002/1097-0142(19950801)76:3<343::aid-cncr2820760302>3.0.co;2-v.

7

Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: a comparison of efficacy, side-effect profile, and cost.托烷司琼、昂丹司琼和格拉司琼用于控制土耳其癌症患者化疗引起的呕吐：疗效、副作用及成本比较

Cancer Invest. 2007 Apr-May;25(3):135-9. doi: 10.1080/07357900701208709.

8

A meta-analysis comparing the efficacy of four 5-HT3-receptor antagonists for acute chemotherapy-induced emesis.一项比较四种5-羟色胺3受体拮抗剂对急性化疗引起的呕吐疗效的荟萃分析。

Support Care Cancer. 2007 Sep;15(9):1023-33. doi: 10.1007/s00520-006-0186-7. Epub 2007 Jan 5.

9

Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.格拉司琼、昂丹司琼和托烷司琼预防顺铂治疗头颈癌引起的急性恶心和呕吐的比较：一项随机对照试验。

Cancer. 1996 Mar 1;77(5):941-8.

10

Granisetron (BRL 43694) in the treatment of cytostatic drug-induced emesis: a summary.格拉司琼（BRL 43694）用于治疗细胞毒性药物引起的呕吐：综述

Cancer Treat Rev. 1990 Sep;17(2-3):307-10. doi: 10.1016/0305-7372(90)90062-k.

引用本文的文献

1

Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists.瘙痒的治疗：5-羟色胺3型受体拮抗剂的新适应症。

Clin Investig. 1993 Aug;71(8):659-62. doi: 10.1007/BF00184497.